With the analysis among 159 patents, we discovered top 44 key players by total patent application. FUJIFILM Cellular Dynamics, Inc., Endogena Therapeutics, Inc., Ojai Retinal Technology LLC are dominant in this area. They take 33.96% of the total patent filing.
FUJIFILM Cellular Dynamics, Inc.
Wisconsin, United States
Patent: 20
Endogena Therapeutics, Inc.
California, United States
Patent: 17
Ojai Retinal Technology LLC
California, United States
Patent: 17
Gyroscope Therapeutics Ltd.
Herefordshire, United Kingdom
Patent: 13
Beijing Shi, China
Patent: 6
Astellas Institute for Regenerative Medicine
Massachusetts, United States
Patent: 5
Sumitomo Chemical Co., Ltd.
With the analysis among 45 patents, we discovered top 5 start-ups by total patent application. Endogena Therapeutics, Inc., Gyroscope Therapeutics Ltd., Institut National de la Santé et de la Recherche Médicale are active in this area.
Endogena Therapeutics, Inc.
California, United States
Patent: 17
Gyroscope Therapeutics Ltd.
Herefordshire, United Kingdom
Patent: 13
Institut National de la Santé et de la Recherche Médicale
Beijing Shi, China
Patent: 6
With the analysis among related 162 patents applied in the last 5 years. We discover 51 most active companies in this area. The fast-growing Endogena Therapeutics, Inc., Ojai Retinal Technology LLC, FUJIFILM Cellular Dynamics, Inc. take 28.40% of patent filing during this period.
Endogena Therapeutics, Inc.
California, United States
Patent: 17
Ojai Retinal Technology LLC
California, United States
Patent: 15
FUJIFILM Cellular Dynamics, Inc.
Wisconsin, United States
Patent: 14
Friedrich Miescher Institute
Basel-Stadt, Switzerland
Patent: 13
Beijing Shi, China
Patent: 6
Gyroscope Therapeutics Ltd.
Herefordshire, United Kingdom
Patent: 6
Charité - Universitätsmedizin Berlin
Department of Health & Human Services
Victoria, Australia
Patent: 4
With the analysis among related 162 patents in last 5 years, we discover 37 new entrants. Endogena Therapeutics, Inc., Friedrich Miescher Institute, Chigenovo Co., Ltd. are the most active new entrants in this area.
Endogena Therapeutics, Inc.
California, United States
Patent: 17
Friedrich Miescher Institute
Basel-Stadt, Switzerland
Patent: 13
Beijing Shi, China
Patent: 6
Charité - Universitätsmedizin Berlin
Victoria, Australia
Patent: 4
Department of Health & Human Services
Kumamoto-ken, Japan
Patent: 2
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 2
With the analysis among 61 patents, we discovered top 14 universities and scientific research institutions by total patent application. Friedrich Miescher Institute, Charité - Universitätsmedizin Berlin, University of Melbourne are dominant in this area. They take 40.98% of the total patent filing.
Friedrich Miescher Institute
Basel-Stadt, Switzerland
Patent: 13
Charité - Universitätsmedizin Berlin
Victoria, Australia
Patent: 4
Centre Hospitalier Universitaire de Montpellier
Kumamoto-ken, Japan
Patent: 2
Regents of the University of Colorado
Colorado, United States
Patent: 2
New York, United States
Patent: 1
Jilin Sheng, China
Patent: 1
The University of Western Australia
Tasmania, Australia
Patent: 1